RCKT ROCKET PHARMACEUTICALS
Health Care · Russell 2000
Next earnings: Mon 9 Nov 2026 · estimated
What 16 analyst firms say about ROCKET PHARMACEUTICALS: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
14 rated views · 16 analyst/firm records · 16 firms
Radar score
- Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
- Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD
Recent analyst activity · last 90 days
Our tracked history has 14 reports on RCKT from 8 analyst firms in the last 90 days (16 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 3 left it unchanged and 3 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: Goldman raised its target from $3.00 (set 2 Mar 2026) to $4.00 on 7 Oct 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Bank of America Securities | Jason Zemansky | Buy | 30 Mar 2026 | 9.00 USD |
| Canaccord Genuity | Whitney Ijem | Buy | 1 Jul 2026 | 10.00 USD |
| Cantor Fitzgerald | Josh Schimmer | Buy | 11 Aug 2026 | 15.00 USD |
| Chardan Capital Markets | Keay Nakae | Buy | 7 Oct 2026 | 11.00 USD |
| Evercore ISI | Gavin Clark-Gartner | Hold | 1 Jul 2026 | 5.00 USD |
| Goldman Sachs | Richard Law | Hold | 8 Oct 2026 | 4.00 USD |
| Jefferies | Andrew Tsai | Hold | 7 Oct 2026 | 2.95 USD |
| JPMorgan | Tessa Romero | Sell | 18 Nov 2025 | 263.00 USD |
| Leerink Partners | Roanna Ruiz | Hold | 7 Oct 2026 | 4.00 USD |
| Lifesci Capital | Patrick Dolezal | Buy | 26 Feb 2026 | 12.00 USD |
| Morgan Stanley | Unnamed analyst | — | 8 Jan 2026 | 5.00 USD |
| Needham | Gil Blum | Buy | 16 Sep 2026 | 9.00 USD |
| TD Cowen | Tara Bancroft | Hold | 15 Jun 2026 | — |
| Wedbush | Yun Zhong | Buy | 7 Oct 2026 | 15.00 USD |
| Weiss Ratings | Unnamed analyst | — | 11 Aug 2026 | — |
| Data feed RESEARCH | Research Team | Hold | 15 Jun 2026 | 2.50 USD |
Partial coverage · checked 6 Nov (6 Nov 2026, 06:54 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.